Purchase Order 75D30124P19130
Award Date 6/10/24
Potential Completion Date 7/31/24
Potential Value $6K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the acquisition of MAGNA PURE EQUIPMENT and does not have a set-aside designation. Roche Diagnostics has received multiple prime contract and subcontract awards from various federal agencies to provide...
- This $52,252 firm fixed price purchase order contract was awarded to Roche Diagnostics Corporation by the Centers for Disease Control and Prevention (CDC) on September 2, 2022. The contract is for MAGNAPURE 24, a diagnostic product, with a performance period ending on August 24, 2023. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a manufacturer and distributor of in vitro diagnostic products, laboratory instruments, and associated medical supplies. This contract...
- This $90,000.00 firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation for MAGNA PURE 96 products. The contract has no set-aside designation and has a completion date of July 23, 2022. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. They have previously received prime contract and subcontract awards from various federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the delivery of MAGNA PURE 96 INSTRUMENTS. The contract, which has a potential value of $180,000.00, does not have a set-aside designation and has an anticipated completion date of April 15, 2022. Roche Diagnostics, a foreign-owned, for-profit manufacturer of in vitro diagnostics,...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, laboratory instruments, and associated products and services. The $113,563 contract provides ICF laboratory equipment and maintenance for the CDC's Pittsburgh location. This award is not designated as a set-aside. Roche Diagnostics has received numerous federal contract awards from agencies including the Department...
- This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the purchase of COBAS PURE C303/E402 clinical chemistry analyzers and associated reagents and supplies. The $460,000.00 firm fixed price contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh on April 24, 2023, with an ultimate completion date of December 31, 2023. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned,...
- This is a $97,000.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, titled "MAGNA 96", has an ultimate completion date of November 30, 2015 and does not have a set-aside designation. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment,...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency, to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The award, valued at $29,600.00, is for the supply of ROCHE COBAS 5800 REAGENTS under a firm fixed-price purchase order. The contract has an ultimate completion date of June 1, 2024. Roche Diagnostics...
- This federal contract award, valued at $90,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the delivery of a MAGNA PURE 96 INSTRUMENT and does not have a set-aside designation. Roche Diagnostics has previously received prime contract and subcontract awards from various federal agencies,...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $90,000 firm fixed price purchase order to Roche Diagnostics Corporation. Under this contract, Roche will deliver MAGNA PURE 96 INSTRUMENTS to the CDC location in Castleton, Indiana by September 20, 2023 to support the agency's disease prevention and health promotion efforts. As one of the largest government contractors in the medical device sector, Roche will leverage existing...